Menglin Xu

MedicineMathematicsBiochemistry, Genetics and Molecular BiologyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Bidirectional Association Between Daily Physical Activity and Postconcussion Symptoms Among Youth”.

Bidirectional Association Between Daily Physical Activity and Postconcussion Symptoms Among Youth

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.27486

N/A

0DataRank · unranked

6 citations

Menglin Xu, Lindsay Sullivan, H. Gerry Taylor, Keith Owen Yeates, Jingzhen Yang

Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2633

N/A

0DataRank · unranked

11 citations

Menglin Xu, Sandipkumar Patel, Andrew Johns, Madison Grogan, Mingjia Li +13 more

Treatment with Soluble CD24 Attenuates COVID-19-Associated Systemic Immunopathology

medRxiv(2021)10.1101/2021.08.18.21262258

N/A

0DataRank · unranked

3 citations

Carter Allen, Anna E. Vilgelm, Brian Riesenberg, Kevin P. Weller, Kelsi Reynolds +25 more

Clinical markers of immunotherapy outcomes in advanced sarcoma

BMC Cancer(2023)10.1186/s12885-023-10758-w

N/A

0DataRank · unranked

4 citations

Dionisia Quiroga, Han Gil Kim, Scott Lenobel, Menglin Xu, Hans Iwenofu +5 more

Clinical Characteristics, Patterns of Care, and Treatment Outcomes of Radiation-Associated Sarcomas

Cancers(2024)10.3390/cancers16101918

N/A

0DataRank · unranked

3 citations

Han Gil Kim, Menglin Xu, Tyler Roach, David A. Liebner, David J. Konieczkowski +2 more

Potent Estrogen Receptor β Agonists with Inhibitory Activity In Vitro , Fail to Suppress Xenografts of Endocrine-Resistant Cyclin-dependent Kinase 4/6 inhibitor-Resistant Breast Cancer Cells

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.12.575428

N/A

0DataRank · unranked

0 citations

Christopher C. Coss, Menglin Xu, Jharna Datta, Jasmine M. Manouchehri, Mathew Cherian +1 more